TABLE OF CONTENTS
1 INTRODUCTION 11
1.1 OBJECTIVES OF THE STUDY 11
1.2 MARKET DEFINITION 11
1.3 OVERVIEW OF EUROPE BREAST LESION LOCALIZATION MARKET 11
1.4 CURRENCY AND PRICING 12
1.5 LIMITATION 12
1.6 MARKETS COVERED 13
2 MARKET SEGMENTATION 14
2.1 MARKETS COVERED 14
2.2 GEOGRAPHIC SCOPE 15
2.3 YEARS CONSIDERED FOR THE STUDY 15
2.4 CURRENCY AND PRICING 15
2.5 RESEARCH METHODOLOGY 16
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 19
2.7 SECONDARY SOURCES 20
2.8 ASSUMPTIONS 20
3 MARKET OVERVIEW 21
3.1 DRIVERS 23
3.1.1 TECHNOLOGICAL ADVANCEMENTS IN BREAST LOCALIZATION 23
3.1.2 RISING PREVALENCE OF BREAST CANCERAND INCREASING BREAST CANCER SURGERIES 23
3.1.3 INCREASING NUMBER OF GOVERNMENT AND NON-GOVERNMENT REIMBURSEMENT POLICIES 24
3.1.4 INCREASING AWARENESS AMONG PEOPLE FOR THE DIAGNOSIS OF BREAST CANCER 25
3.1.5 INNOVATIONS OF NEW TECHNOLOGIES AND METHODS FOR BREAST CANCER LESION LOCALIZATION 25
3.2 RESTRAINTS 26
3.2.1 REGULATORY SCENARIOS IN BREAST LOCALIZATION 26
3.2.2 PRODUCT RECALL 26
3.3 OPPORTUNITIES 27
3.3.1 EMERGING MARKET 27
3.3.2 RISING MEDICAL TOURISM 27
3.4 CHALLENGES 27
3.4.1 RISK ASSOCIATED WITH THE BREAST SURGERY AND PAINFUL CONSEQUENCES 27
?
4 EXECUTIVE SUMMARY 28
5 PREMIUM INSIGHTS 30
6 EUROPE BREAST LESION LOCALIZATION METHODS MARKET , BY TYPE 32
6.1 OVERVIEW 33
6.2 WIRE LOCALIZATION 34
6.3 RADIOISOTOPE LOCALIZATION 34
6.3.1 RADIOACTIVE SEED LOCALIZATION 35
6.3.2 RADIO OCCULT LESION LOCALIZATION 35
6.4 MEGNATIC TRACERS 35
6.5 OTHERS 35
7 EUROPE BREAST LESION LOCALIZATION METHODS MARKET ,
BY BIOPSY TECHNIQUE 36
7.1 OVERVIEW 37
7.2 FINE NEEDLE ASPIRATION BIOPSY 38
7.3 VACUUM ASSISTED CORE BIOPSY 38
7.4 CORE NEEDLE BIOPSY 38
7.5 SURGICAL BIOPSY 38
7.5.1 EXCISIONAL BIOPSY 39
7.5.2 INCISIONAL BIOPSY 39
8 EUROPE BREAST LESION LOCALIZATION METHODS MARKET , BY END USER 40
8.1 OVERVIEW 41
8.2 HOSPITALS 42
8.3 ONCOLOGY CLINICS 42
8.4 DIAGNOSTIC CENTERS 42
8.5 AMBULATORY SURGICAL CENTERS 42
9 EUROPE BREAST LESION LOCALIZATION METHODS MARKET, BY COUNTRY 43
9.1.1 GERMANY 47
9.1.2 FRANCE 50
9.1.3 U.K. 53
9.1.4 ITALY 56
9.1.5 SPAIN 59
9.1.6 RUSSIA 62
9.1.7 SWITZERLAND 65
9.1.8 NETHERLANDS 68
9.1.9 TURKEY 71
9.1.10 BELGIUM 74
9.1.11 REST OF EUROPE 77
10 EUROPE BREAST LESION LOCALIZATION METHODS MARKET,
COMPANY LANDSCAPE 78
10.1 COMPANY SHARE ANALYSIS; EUROPE 78
11 COMPANY PROFILES 79
11.1 C. R. BARD, INC. 79
11.1.1 COMPANY OVERVIEW 79
11.1.2 REVENUE ANALYSIS 79
11.1.3 PRODUCT PORTFOLIO 80
11.1.4 RECENT DEVELOPMENTS 80
11.2 CP MEDICAL, INC. 81
11.2.1 COMPANY OVERVIEW 81
11.2.2 COMPANY SNAPSHOT 81
11.2.3 PRODUCT PORTFOLIO 81
11.2.4 RECENT DEVELOPMENTS 81
11.3 CIANNA MEDICAL 82
11.3.1 COMPANY OVERVIEW 82
11.3.2 REVENUE ANALYSIS 82
11.3.3 PRODUCT PORTFOLIO 82
11.3.4 RECENT DEVELOPMENTS 82
11.4 COOK GROUP 83
11.4.1 COMPANY OVERVIEW 83
11.4.2 COMPANY SNAPSHOT 83
11.4.3 PRODUCT PORTFOLIO 83
11.4.4 RECENT DEVELOPMENTS 83
11.5 STERYLAB S.R.L. 84
11.5.1 COMPANY OVERVIEW 84
11.5.2 COMPANY SNAPSHOT 84
11.5.3 PRODUCT PORTFOLIO 84
11.5.4 RECENT DEVELOPMENTS 84
11.6 SOMATEX MEDICAL TECHNOLOGIES GMBH 85
11.6.1 COMPANY OVERVIEW 85
11.6.2 COMPANY SNAPSHOT 85
11.6.3 PRODUCT PORTFOLIO 85
11.6.4 RECENT DEVELOPMENTS 86
?
11.7 ELUCENT MEDICAL. 87
11.7.1 COMPANY OVERVIEW 87
11.7.2 COMPANY SNAPSHOT 87
11.7.3 PRODUCT PORTFOLIO 87
11.7.4 RECENT DEVELOPMENTS 87
11.8 ARGON MEDICAL 88
11.8.1 COMPANY OVERVIEW 88
11.8.2 COMPANY SNAPSHOT 88
11.8.3 PRODUCT PORTFOLIO 88
11.8.4 RECENT DEVELOPMENTS 88
11.9 TSUNAMI S.R.L. 89
11.9.1 COMPANY OVERVIEW 89
11.9.2 COMPANY SNAPSHOT 89
11.9.3 PRODUCT PORTFOLIO 89
11.9.4 RECENT DEVELOPMENTS 89
11.10 M.D.L. SRL 90
11.10.1 COMPANY OVERVIEW 90
11.10.2 COMPANY SNAPSHOT 90
11.10.3 PRODUCT PORTFOLIO 90
11.10.4 RECENT DEVELOPMENTS 90
11.11 BIOMEDICAL SRL 91
11.11.1 COMPANY OVERVIEW 91
11.11.2 COMPANY SNAPSHOT 91
11.11.3 PRODUCT PORTFOLIO 91
11.11.4 RECENT DEVELOPMENTS 91
12 RELATED REPORTS 92